-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid, also known as Cyp2C9, is an important intermediate in the pharmaceutical and chemical industries.
It is used as a building block for the synthesis of various drugs and other chemicals.
In this article, we will discuss the upstream and downstream products of Cyp2C9 in the chemical industry.
Upstream Products
The upstream products of Cyp2C9 are the raw materials needed for its synthesis.
The most common upstream products are pyrrole and 7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine, which are both available in the market.
Pyrrole is a colorless liquid with a strong amyl alcohol-like odor, while 7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine is a solid that is slightly soluble in water.
Downstream Products
The downstream products of Cyp2C9 are the chemicals and drugs that are synthesized using Cyp2C9 as a building block.
The most common downstream products are anticoagulants, antiplatelet agents, and immunosuppressants.
These drugs are used to treat a variety of medical conditions, including heart disease, stroke, and autoimmune disorders.
One of the most commonly synthesized downstream products of Cyp2C9 is the anticoagulant drug known as clopidogrel.
Clopidogrel is used to prevent blood clots from forming in the arteries and veins, which can cause heart attack and stroke.
Cyp2C9 is used as an intermediate in the synthesis of clopidogrel.
Another important downstream product of Cyp2C9 is the immunosuppressant drug known as cyclosporine.
Cyclosporine is used to prevent the rejection of transplanted organs and to treat autoimmune disorders such as psoriasis and rheumatoid arthritis.
Cyp2C9 is also used as an intermediate in the synthesis of cyclosporine.
Manufacturing Process
The manufacturing process for Cyp2C9 involves several steps, including the synthesis of pyrrole and 7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine, and their subsequent condensation to form Cyp2C9.
The synthesis of these precursors involves the use of various chemical reactions, including nitration, hydrolysis, and condensation reactions.
The synthesis of pyrrole involves the reaction of ammonia and hydrocyanic acid, followed by the addition of cyanogen bromide.
The synthesis of 7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine involves the reaction of 7-amino-5-chloro-6-oxo-2H-pyrrolo[2,3-d]pyrimidine with propylene oxide.
Once the precursors are synthesized, they are condensed using condensation reactions such as the Knoevenagel reaction or the Vogel-Schwartz reaction to form Cyp2C9.
The Knoevenagel reaction involves the condensation of pyrrole with an aminocarbonyl compound in the presence of a bases such as sodium hydroxide, while the Vogel-Schwartz reaction involves the condensation of 7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine with an aldehyde in the presence of a base such as sodium hydroxide.
Quality Control
The quality of Cyp2C9 is crucial for the synthesis of downstream products.
To ensure the quality of the product, various tests are performed during the manufacturing process, including chemical tests such as TLC, HPLC, and mass spectrometry, and physical tests such as melting point and solubility tests.
In addition, the purity of the